Your browser doesn't support javascript.
loading
Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older.
Oberic, Lucie; Peyrade, Frederic; Puyade, Mathieu; Bonnet, Christophe; Dartigues-Cuillères, Peggy; Fabiani, Bettina; Ruminy, Philippe; Maisonneuve, Hervé; Abraham, Julie; Thieblemont, Catherine; Feugier, Pierre; Salles, Gilles; Bijou, Fontanet; Pica, Gian-Matteo; Damaj, Gandhi; Haioun, Corinne; Casasnovas, René-Olivier; Farhat, Hassan; Le Calloch, Ronan; Waultier-Rascalou, Agathe; Malak, Sandra; Paget, Jerome; Gat, Elodie; Tilly, Hervé; Jardin, Fabrice.
Afiliación
  • Oberic L; Department of Hematology, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France.
  • Peyrade F; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Puyade M; Department of Oncology-Haematology and Cell Therapy, CHU, Poitiers, INSERM, Inserm CIC 1402, Poitiers, France.
  • Bonnet C; Clinical Hematology Unit, CHU Liège, Liège Université, Campus Universitaire de Sart Tilman, Liège, Belgique.
  • Dartigues-Cuillères P; Anapath Research Unit (EA) EA4340 and Pathology Laboratory, Versailles University and APHP, Ambroise Paré Hospital, Boulogne, France.
  • Fabiani B; Department of Pathology, Hopital Saint-Antoine, APHP, Paris, France.
  • Ruminy P; INSERM U1245, Centre Henri Becquerel, Rouen, France.
  • Maisonneuve H; Department of Clinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France.
  • Abraham J; Department of Hematology, CHU Dupuytren, Limoges, France.
  • Thieblemont C; APHP, Hopital Saint-Louis, Hemato-oncologie; Université de Paris, Paris Diderot, Paris, France.
  • Feugier P; Department of Haematology, Centre Hospitalier Régional Universitaire de Nancy, Vandoeuvre Les Nancy, France.
  • Salles G; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France.
  • Bijou F; Department of Hematology, Hospital Bergonié, Bordeaux, France.
  • Pica GM; Department of Hematology, Centre Hospitalier Métropole Savoie, Chambery, France.
  • Damaj G; Department of Hematology, CHU Caen, Caen, France.
  • Haioun C; Department of Hematology, Henri Mondor University Hospital, UPEC, Creteil, France.
  • Casasnovas RO; Department of Hematology and INSERM1231, CHU Dijon Bourgogne, Dijon, France.
  • Farhat H; Department of Hematology, Centre Hospitalier de Versailles André Mignot, Versailles, France.
  • Le Calloch R; Centre hospitalier de Quimper Cornouaille/Université de Bretagne Occidentale, France.
  • Waultier-Rascalou A; Department of Hematology, Centre Hospitalier Universitaire Nimes Caremeau, Nîmes, France.
  • Malak S; Department of Hematology, CLCC Rene Huguenin Institut Curie, Saint-Cloud, France.
  • Paget J; LYSARC, The Lymphoma Academic Research Organisation, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
  • Gat E; LYSARC, The Lymphoma Academic Research Organisation, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
  • Tilly H; Department of Hematology, Centre Henri Becquerel, UNIROUEN, University of Normandy, INSERM U1245, Rouen, France.
  • Jardin F; Department of Hematology, Centre Henri Becquerel, UNIROUEN, University of Normandy, INSERM U1245, Rouen, France.
J Clin Oncol ; 39(11): 1203-1213, 2021 04 10.
Article en En | MEDLINE | ID: mdl-33444079
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Factor de Transcripción CHOP / Rituximab / Lenalidomida Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged80 / Humans / Male Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Factor de Transcripción CHOP / Rituximab / Lenalidomida Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged80 / Humans / Male Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Francia